EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum levels of IFN-γ and NGF as potential biomarkers of depressive disorders

Lei Yi, Chuanqin Liu, Wei Lin, Ni Duan iD

Acta Neuropsychiatrica · 2026 · 38

DOI: 10.1017/neu.2026.10079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, online erschienen am 25.06.2026. Verfasst von Lei Yi und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department, Qingdao Mental Health Center, Qingdao 266034, Shandong, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depressive disorder (DD) is a widespread mental illness that lacks objective diagnostic biomarkers, complicating early detection and personalised treatment. This study investigated the diagnostic value of serum interferon-gamma (IFN-γ), nerve growth factor (NGF), and their ratio, alongside thyroid peroxidase antibody (TPOAb) and glial fibrillary acidic protein (GFAP), in patients with DD compared to healthy controls.

Methods

A total of 238 participants (118 with DD and 120 controls) were enrolled. Depression severity was assessed using DSM-5 and HAM-D criteria. Serum biomarkers were measured using enzyme-linked immunosorbent assays (ELISA), and receiver operating characteristic (ROC) analysis was performed to assess diagnostic performance.

Results

DD patients exhibited significantly lower IFN-γ and higher NGF levels than controls (both p < 0.001), resulting in a markedly reduced IFN-γ/NGF ratio. The IFN-γ/NGF ratio achieved the highest diagnostic accuracy (AUC = 0.858, sensitivity = 82.20%, specificity = 77.50%), outperforming IFN-γ (AUC = 0.766) and NGF (AUC = 0.848) alone. TPOAb and GFAP levels did not differ significantly between groups.

Conclusion

The IFN-γ/NGF ratio is a promising biomarker for depressive disorder, offering superior diagnostic accuracy over individual immune or neurotrophic markers. This composite index may support more objective and biologically informed diagnosis in clinical psychiatry.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersDepressive disorderDiagnosisImmune responseNeurotrophic factors

Autor:innen und Institutionen

  • The Third Department, Qingdao Mental Health Center, Qingdao 266034, Shandong, China.
  • Department of Sleep Medicine, Qingdao Mental Health Center, Qingdao 266034, Shandong, China.

ORCID-Profile: Ni Duan

Zitieren

APA

Yi, L., Liu, C., Lin, W., & Duan, N. (2026). Serum levels of IFN-γ and NGF as potential biomarkers of depressive disorders. Acta Neuropsychiatrica, 38. https://doi.org/10.1017/neu.2026.10079

Vancouver

Yi L, Liu C, Lin W, Duan N. Serum levels of IFN-γ and NGF as potential biomarkers of depressive disorders. Acta Neuropsychiatrica. 2026;38. doi:10.1017/neu.2026.10079

BibTeX
@article{Yi2026,
  author = {Yi, Lei and Liu, Chuanqin and Lin, Wei and Duan, Ni},
  title = {Serum levels of IFN-γ and NGF as potential biomarkers of depressive disorders},
  journal = {Acta Neuropsychiatrica},
  year = {2026},
  volume = {38},
  doi = {10.1017/neu.2026.10079}
}
Kostenlos starten →